Current report filing

Note 3 - Discontinued Operations (Tables)

v3.8.0.1
Note 3 - Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2016
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   
December
31,
201
6
    
December 31,
201
5
  
Accounts and other receivables
   $
1,598,994
     $
3,692,747
  
Inventory, net
    
1,374,618
      
652,906
  
Prepaid expenses
    
170,635
      
172,585
  
Assets associated with discontinued operations, current
    
3,144,247
      
4,518,238
  
Property and equipment, net of accumulated depreciation
    
70,973
      
151,412
  
Patents and trademarks, net of accumulated amortization
    
34,282
      
39,473
  
Assets associated with discontinued operations, noncurrent
    
105,255
      
190,885
  
Total assets associated with discontinued operations
   $
3,249,502
     $
4,709,123
  
                 
Accounts payable
   $
1,957,938
     $
242,220
  
Accrued liabilities
    
607,659
      
859,365
  
Deferred revenue
    
2,300,000
      
—
  
Liabilities associated with discontinued operations, current
    
4,865,597
      
1,101,585
  
Other liabilities
    
—
      
1,000,000
  
Total l
iabilities associated with discontinued operations
   $
4,865,597
     $
2,101,585
  
   
Years Ended December 31,
  
   
2016
    
2015
    
2014
  
Revenue:
                        
Lymphoseek
sales revenue
   $
16,997,497
     $
10,235,277
     $
4,220,753
  
Royalties on GDS Business
    
—
      
1,194,660
      
—
  
Grant and other revenue
    
575
      
669
      
—
  
Total revenue
    
16,998,072
      
11,430,606
      
4,220,753
  
Cost of goods sold
    
2,234,780
      
1,751,537
      
1,583,519
  
Gross profit
    
14,763,292
      
9,679,069
      
2,637,234
  
Operating expenses:
                        
Research and development
    
1,744,496
      
2,225,004
      
1,662,611
  
Selling, general and administrative
    
5,093,529
      
6,369,183
      
6,016,087
  
Total operating expenses
    
6,838,025
      
8,594,187
      
7,678,698
  
Income (l
oss) from discontinued operations
    
7,925,267
      
1,084,882
      
(5,041,464
)
Interest expense
    
(14,856,404
)
    
(5,603,820
)
    
(326,337
)
Loss from
discontinued operations
   $
(6,931,137
)
   $
(4,518,938
)
   $
(5,367,801
)